 | • レポートコード：GIR-23F0317 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Antidotes Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の解毒剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 解毒剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・注射用、経口用 アプリケーション別セグメントは次のように区分されます。 ・病院、診療所 世界の解毒剤市場の主要なマーケットプレーヤーは以下のとおりです。 ・Baxter、Fresenius Kabi、Sandoz、Roche、Mylan、Pfizer、Teva、Glaxosmithkline、Merck 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 解毒剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：注射用、経口用 - アプリケーション別分析（2017年vs2021年vs2028年）：病院、診療所 - 世界の解毒剤市場規模・予測 - 世界の解毒剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Baxter、Fresenius Kabi、Sandoz、Roche、Mylan、Pfizer、Teva、Glaxosmithkline、Merck ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：注射用、経口用 ・アプリケーション別分析2017年-2028年：病院、診療所 ・解毒剤の北米市場分析 - 解毒剤の北米市場：タイプ別市場規模2017年-2028年 - 解毒剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・解毒剤のヨーロッパ市場分析 - ：解毒剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：解毒剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・解毒剤のアジア太平洋市場分析 - 解毒剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 解毒剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・解毒剤の南米市場分析 - 解毒剤の南米市場：タイプ別市場規模2017年-2028年 - 解毒剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・解毒剤の中東・アフリカ市場分析 - 解毒剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 解毒剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Antidotes market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Antidotes market size is estimated to be worth US$ 8651.4 million in 2021 and is forecast to a readjusted size of USD 10570 million by 2028 with a CAGR of 2.9% during review period. Hospital accounting for % of the Antidotes global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Antidotes include Baxter, Fresenius Kabi, Sandoz, Roche, and Mylan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Antidotes market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Oral
Market segment by Application can be divided into
Hospital
Clinic
The key market players for global Antidotes market are listed below:
Baxter
Fresenius Kabi
Sandoz
Roche
Mylan
Pfizer
Teva
Glaxosmithkline
Merck
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antidotes product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Antidotes, with price, sales, revenue and global market share of Antidotes from 2019 to 2022.
Chapter 3, the Antidotes competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antidotes breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Antidotes market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antidotes.
Chapter 13, 14, and 15, to describe Antidotes sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Antidotes Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Antidotes Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Injection
1.2.3 Oral
1.3 Market Analysis by Application
1.3.1 Overview: Global Antidotes Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Antidotes Market Size & Forecast
1.4.1 Global Antidotes Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Antidotes Sales in Volume (2017-2028)
1.4.3 Global Antidotes Price (2017-2028)
1.5 Global Antidotes Production Capacity Analysis
1.5.1 Global Antidotes Total Production Capacity (2017-2028)
1.5.2 Global Antidotes Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Antidotes Market Drivers
1.6.2 Antidotes Market Restraints
1.6.3 Antidotes Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Antidotes Product and Services
2.1.4 Baxter Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Fresenius Kabi
2.2.1 Fresenius Kabi Details
2.2.2 Fresenius Kabi Major Business
2.2.3 Fresenius Kabi Antidotes Product and Services
2.2.4 Fresenius Kabi Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sandoz
2.3.1 Sandoz Details
2.3.2 Sandoz Major Business
2.3.3 Sandoz Antidotes Product and Services
2.3.4 Sandoz Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Antidotes Product and Services
2.4.4 Roche Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Mylan
2.5.1 Mylan Details
2.5.2 Mylan Major Business
2.5.3 Mylan Antidotes Product and Services
2.5.4 Mylan Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Antidotes Product and Services
2.6.4 Pfizer Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Teva
2.7.1 Teva Details
2.7.2 Teva Major Business
2.7.3 Teva Antidotes Product and Services
2.7.4 Teva Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Glaxosmithkline
2.8.1 Glaxosmithkline Details
2.8.2 Glaxosmithkline Major Business
2.8.3 Glaxosmithkline Antidotes Product and Services
2.8.4 Glaxosmithkline Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Antidotes Product and Services
2.9.4 Merck Antidotes Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Antidotes Breakdown Data by Manufacturer
3.1 Global Antidotes Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Antidotes Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Antidotes
3.4 Market Concentration Rate
3.4.1 Top 3 Antidotes Manufacturer Market Share in 2021
3.4.2 Top 6 Antidotes Manufacturer Market Share in 2021
3.5 Global Antidotes Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Antidotes Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Antidotes Market Size by Region
4.1.1 Global Antidotes Sales in Volume by Region (2017-2028)
4.1.2 Global Antidotes Revenue by Region (2017-2028)
4.2 North America Antidotes Revenue (2017-2028)
4.3 Europe Antidotes Revenue (2017-2028)
4.4 Asia-Pacific Antidotes Revenue (2017-2028)
4.5 South America Antidotes Revenue (2017-2028)
4.6 Middle East and Africa Antidotes Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Antidotes Sales in Volume by Type (2017-2028)
5.2 Global Antidotes Revenue by Type (2017-2028)
5.3 Global Antidotes Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Antidotes Sales in Volume by Application (2017-2028)
6.2 Global Antidotes Revenue by Application (2017-2028)
6.3 Global Antidotes Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Antidotes Sales by Type (2017-2028)
7.2 North America Antidotes Sales by Application (2017-2028)
7.3 North America Antidotes Market Size by Country
7.3.1 North America Antidotes Sales in Volume by Country (2017-2028)
7.3.2 North America Antidotes Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Antidotes Sales by Type (2017-2028)
8.2 Europe Antidotes Sales by Application (2017-2028)
8.3 Europe Antidotes Market Size by Country
8.3.1 Europe Antidotes Sales in Volume by Country (2017-2028)
8.3.2 Europe Antidotes Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Antidotes Sales by Type (2017-2028)
9.2 Asia-Pacific Antidotes Sales by Application (2017-2028)
9.3 Asia-Pacific Antidotes Market Size by Region
9.3.1 Asia-Pacific Antidotes Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Antidotes Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Antidotes Sales by Type (2017-2028)
10.2 South America Antidotes Sales by Application (2017-2028)
10.3 South America Antidotes Market Size by Country
10.3.1 South America Antidotes Sales in Volume by Country (2017-2028)
10.3.2 South America Antidotes Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Antidotes Sales by Type (2017-2028)
11.2 Middle East & Africa Antidotes Sales by Application (2017-2028)
11.3 Middle East & Africa Antidotes Market Size by Country
11.3.1 Middle East & Africa Antidotes Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Antidotes Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Antidotes and Key Manufacturers
12.2 Manufacturing Costs Percentage of Antidotes
12.3 Antidotes Production Process
12.4 Antidotes Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Antidotes Typical Distributors
13.3 Antidotes Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Antidotes Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Antidotes Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Baxter Basic Information, Manufacturing Base and Competitors
Table 4. Baxter Major Business
Table 5. Baxter Antidotes Product and Services
Table 6. Baxter Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 8. Fresenius Kabi Major Business
Table 9. Fresenius Kabi Antidotes Product and Services
Table 10. Fresenius Kabi Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sandoz Basic Information, Manufacturing Base and Competitors
Table 12. Sandoz Major Business
Table 13. Sandoz Antidotes Product and Services
Table 14. Sandoz Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Roche Basic Information, Manufacturing Base and Competitors
Table 16. Roche Major Business
Table 17. Roche Antidotes Product and Services
Table 18. Roche Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Mylan Basic Information, Manufacturing Base and Competitors
Table 20. Mylan Major Business
Table 21. Mylan Antidotes Product and Services
Table 22. Mylan Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Antidotes Product and Services
Table 26. Pfizer Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Teva Basic Information, Manufacturing Base and Competitors
Table 28. Teva Major Business
Table 29. Teva Antidotes Product and Services
Table 30. Teva Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Glaxosmithkline Basic Information, Manufacturing Base and Competitors
Table 32. Glaxosmithkline Major Business
Table 33. Glaxosmithkline Antidotes Product and Services
Table 34. Glaxosmithkline Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Merck Basic Information, Manufacturing Base and Competitors
Table 36. Merck Major Business
Table 37. Merck Antidotes Product and Services
Table 38. Merck Antidotes Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Antidotes Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 40. Global Antidotes Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Antidotes, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Antidotes Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 43. Head Office and Antidotes Production Site of Key Manufacturer
Table 44. Antidotes New Entrant and Capacity Expansion Plans
Table 45. Antidotes Mergers & Acquisitions in the Past Five Years
Table 46. Global Antidotes Sales by Region (2017-2022) & (Kiloton)
Table 47. Global Antidotes Sales by Region (2023-2028) & (Kiloton)
Table 48. Global Antidotes Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Antidotes Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Antidotes Sales by Type (2017-2022) & (Kiloton)
Table 51. Global Antidotes Sales by Type (2023-2028) & (Kiloton)
Table 52. Global Antidotes Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Antidotes Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Antidotes Price by Type (2017-2022) & (US$/Ton)
Table 55. Global Antidotes Price by Type (2023-2028) & (US$/Ton)
Table 56. Global Antidotes Sales by Application (2017-2022) & (Kiloton)
Table 57. Global Antidotes Sales by Application (2023-2028) & (Kiloton)
Table 58. Global Antidotes Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Antidotes Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Antidotes Price by Application (2017-2022) & (US$/Ton)
Table 61. Global Antidotes Price by Application (2023-2028) & (US$/Ton)
Table 62. North America Antidotes Sales by Country (2017-2022) & (Kiloton)
Table 63. North America Antidotes Sales by Country (2023-2028) & (Kiloton)
Table 64. North America Antidotes Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Antidotes Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Antidotes Sales by Type (2017-2022) & (Kiloton)
Table 67. North America Antidotes Sales by Type (2023-2028) & (Kiloton)
Table 68. North America Antidotes Sales by Application (2017-2022) & (Kiloton)
Table 69. North America Antidotes Sales by Application (2023-2028) & (Kiloton)
Table 70. Europe Antidotes Sales by Country (2017-2022) & (Kiloton)
Table 71. Europe Antidotes Sales by Country (2023-2028) & (Kiloton)
Table 72. Europe Antidotes Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Antidotes Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Antidotes Sales by Type (2017-2022) & (Kiloton)
Table 75. Europe Antidotes Sales by Type (2023-2028) & (Kiloton)
Table 76. Europe Antidotes Sales by Application (2017-2022) & (Kiloton)
Table 77. Europe Antidotes Sales by Application (2023-2028) & (Kiloton)
Table 78. Asia-Pacific Antidotes Sales by Region (2017-2022) & (Kiloton)
Table 79. Asia-Pacific Antidotes Sales by Region (2023-2028) & (Kiloton)
Table 80. Asia-Pacific Antidotes Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Antidotes Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Antidotes Sales by Type (2017-2022) & (Kiloton)
Table 83. Asia-Pacific Antidotes Sales by Type (2023-2028) & (Kiloton)
Table 84. Asia-Pacific Antidotes Sales by Application (2017-2022) & (Kiloton)
Table 85. Asia-Pacific Antidotes Sales by Application (2023-2028) & (Kiloton)
Table 86. South America Antidotes Sales by Country (2017-2022) & (Kiloton)
Table 87. South America Antidotes Sales by Country (2023-2028) & (Kiloton)
Table 88. South America Antidotes Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Antidotes Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Antidotes Sales by Type (2017-2022) & (Kiloton)
Table 91. South America Antidotes Sales by Type (2023-2028) & (Kiloton)
Table 92. South America Antidotes Sales by Application (2017-2022) & (Kiloton)
Table 93. South America Antidotes Sales by Application (2023-2028) & (Kiloton)
Table 94. Middle East & Africa Antidotes Sales by Region (2017-2022) & (Kiloton)
Table 95. Middle East & Africa Antidotes Sales by Region (2023-2028) & (Kiloton)
Table 96. Middle East & Africa Antidotes Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Antidotes Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Antidotes Sales by Type (2017-2022) & (Kiloton)
Table 99. Middle East & Africa Antidotes Sales by Type (2023-2028) & (Kiloton)
Table 100. Middle East & Africa Antidotes Sales by Application (2017-2022) & (Kiloton)
Table 101. Middle East & Africa Antidotes Sales by Application (2023-2028) & (Kiloton)
Table 102. Antidotes Raw Material
Table 103. Key Manufacturers of Antidotes Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Antidotes Typical Distributors
Table 107. Antidotes Typical Customers
List of Figures
Figure 1. Antidotes Picture
Figure 2. Global Antidotes Revenue Market Share by Type in 2021
Figure 3. Injection
Figure 4. Oral
Figure 5. Global Antidotes Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global Antidotes Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 9. Global Antidotes Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Antidotes Sales (2017-2028) & (Kiloton)
Figure 11. Global Antidotes Price (2017-2028) & (US$/Ton)
Figure 12. Global Antidotes Production Capacity (2017-2028) & (Kiloton)
Figure 13. Global Antidotes Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Antidotes Market Drivers
Figure 15. Antidotes Market Restraints
Figure 16. Antidotes Market Trends
Figure 17. Global Antidotes Sales Market Share by Manufacturer in 2021
Figure 18. Global Antidotes Revenue Market Share by Manufacturer in 2021
Figure 19. Antidotes Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Antidotes Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Antidotes Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Antidotes Sales Market Share by Region (2017-2028)
Figure 23. Global Antidotes Revenue Market Share by Region (2017-2028)
Figure 24. North America Antidotes Revenue (2017-2028) & (USD Million)
Figure 25. Europe Antidotes Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Antidotes Revenue (2017-2028) & (USD Million)
Figure 27. South America Antidotes Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Antidotes Revenue (2017-2028) & (USD Million)
Figure 29. Global Antidotes Sales Market Share by Type (2017-2028)
Figure 30. Global Antidotes Revenue Market Share by Type (2017-2028)
Figure 31. Global Antidotes Price by Type (2017-2028) & (US$/Ton)
Figure 32. Global Antidotes Sales Market Share by Application (2017-2028)
Figure 33. Global Antidotes Revenue Market Share by Application (2017-2028)
Figure 34. Global Antidotes Price by Application (2017-2028) & (US$/Ton)
Figure 35. North America Antidotes Sales Market Share by Type (2017-2028)
Figure 36. North America Antidotes Sales Market Share by Application (2017-2028)
Figure 37. North America Antidotes Sales Market Share by Country (2017-2028)
Figure 38. North America Antidotes Revenue Market Share by Country (2017-2028)
Figure 39. United States Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Antidotes Sales Market Share by Type (2017-2028)
Figure 43. Europe Antidotes Sales Market Share by Application (2017-2028)
Figure 44. Europe Antidotes Sales Market Share by Country (2017-2028)
Figure 45. Europe Antidotes Revenue Market Share by Country (2017-2028)
Figure 46. Germany Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Antidotes Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Antidotes Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Antidotes Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Antidotes Revenue Market Share by Region (2017-2028)
Figure 55. China Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Antidotes Sales Market Share by Type (2017-2028)
Figure 62. South America Antidotes Sales Market Share by Application (2017-2028)
Figure 63. South America Antidotes Sales Market Share by Country (2017-2028)
Figure 64. South America Antidotes Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Antidotes Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Antidotes Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Antidotes Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Antidotes Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Antidotes Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Antidotes in 2021
Figure 76. Manufacturing Process Analysis of Antidotes
Figure 77. Antidotes Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
• 英文レポート名：Global Antidotes Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
• 日本語訳：解毒剤のグローバル市場2022年
• レポートコード：GIR-23F0317 ▷ お問い合わせ（見積依頼・ご注文・質問）